Provided are: an antibody which specifically binds to an ALK2 protein and has an activity of inhibiting BMP signal transduction mediated by ALK2; a method for producing the antibody; and a pharmaceutical composition containing the antibody for treating and/or preventing heterotopic ossification and/or osteodystrophy, anemia, or diffuse intrinsic pontine glioma (DIPG).